Omeros (OMER) Current Leases (2018 - 2026)
Omeros (OMER) reported Current Leases of $6.4 million for Q1 2026, up 5.91% on a YoY basis from $6.1 million in Q1 2025, and up 1.81% sequentially from $6.3 million in Q4 2025.
Omeros (OMER) Current Leases (2018 - 2026) Analysis & Trends
Omeros (OMER) has 9 years of Current Leases data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 5.91% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 5.91% YoY), and the FY2025 full-year result was $6.3 million, up 5.51% from the prior year.
- Current Leases climbed to $6.4 million in Q1 2026, from $6.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $6.4 million in Q1 2026 to a low of $3.9 million in Q1 2022.
- A 5-year average of $5.3 million and a median of $5.3 million in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases declined 17.98% in 2022 and gained 20.67% in 2024, its largest moves.
- Tracing OMER's Current Leases over 5 years: stood at $4.3 million in 2022, then gained by 19.72% to $5.2 million in 2023, then climbed by 15.72% to $6.0 million in 2024, then advanced by 5.51% to $6.3 million in 2025, then climbed by 1.81% to $6.4 million in 2026.
- Business Quant data shows OMER's Current Leases at $6.4 million in Q1 2026, $6.3 million in Q4 2025, and $6.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 6.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.41 Mn |
| Dec 31, 2025 | 6.30 Mn |
| Sep 30, 2025 | 6.18 Mn |
| Jun 30, 2025 | 6.15 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 5.97 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 5.57 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 4.41 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | 5.26 Mn |
| Sep 30, 2021 | 5.09 Mn |
| Jun 30, 2021 | 4.87 Mn |